 OUTLINE: This is a randomized, double-blind, multicenter, pilot study. Patients are stratified according to age under 18 vs 18 and over and absolute neutrophil count less than 500mm3 vs at least 500mm3. Patients are randomized to 1 of 2 treatment arms. 